
Please try another search
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for autoimmune diseases using its Kinoid technology. The company’s product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of lupus erythematosus; and Phase IIa clinical trial for the treatment of dermatomyositis; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company was founded in 1993 and is based in Paris, France.
Name | Age | Since | Title |
---|---|---|---|
Daniel Zagury | - | 2011 | Founder, Chairman of Scientific Research Committee & Director |
Hugo Brugiere | - | - | Chairman, GM & CEO |
Miriam Merad | - | - | Member of Scientific Advisory Board |
Ingrid Lundberg | - | 2015 | Member of Clinical Advisory Board |
Thomas Kündig | 62 | - | Member of Scientific Research Committee |
Arsène Burny | - | - | Member of Scientific Research Committee |
Marie-Christophe Boissier | - | - | Member of Scientific Research Committee |
Eric Hachulla | - | 2015 | Member of Clinical Advisory Board |
Baudouin Hallo | - | - | Director |
Bernard Fanget | - | 2024 | VP of Pharmaceutical Affairs & Director |
Robert C. Gallo | 88 | - | Vice Chairman of Scientific Research Committee |
Martine Bagot | - | - | Member of Scientific Research Committee |
Bernard Lauwerys | - | - | Member of Scientific Advisory Board |
Olivier Benveniste | - | 2015 | Member of Clinical Advisory Board |
Virginia Pascual | - | - | Member of Medical & Scientific Advisory Board |
Laurence Zitvogel | 60 | - | Member of Scientific Advisory Board |
Muriel Haim | - | - | Director |
Armand Bensussan | - | - | Vice Chairman of Scientific Research Committee |
François Sigaux | - | - | Member of Scientific Research Committee |
Jean-David Bouaziz | - | 2015 | Member of Clinical Advisory Board |
Werner Stenzel | - | 2015 | Member of Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review